RxDoctor Payments Data

Zef Markaj, DPM

Podiatrist · Warren, MINPI 1538720958

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (56.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Pinnacle, Inc at 27.4% of the total. Reporting peaked in 2023 at $2,204 and has fallen 81.0% since, to $418 in 2025.

$6,089in general payments, 2019–2025

Across 90 payments — averaging $67.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pinnacle, Inc$2K
  • Paragon 28, Inc.$1K
  • Stryker$640
  • Arthrex$478
  • Osteomed LLC$318
  • Tactile Systems Technology Inc$279
  • plus $2K from 27 others

What the payments were for

  • Travel & lodging$1,53825%
  • Food & beverage$3,46157%
  • Education$1,09118%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,089 in reported general payments places this provider in the 85th percentile of 302 podiatrist providers in Michigan.

See all podiatrist providers in Michigan

Medicare billing

Part B allowed, 2024
$1,056,141
Medicare patients
430
Services billed
3,033

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole173$3,730
Ammonium Lactate173$2,211
Diclofenac Sodium64$1,183
Ciclopirox18$296
Cephalexin37$197
Silver Sulfadiazine16$189
Gabapentin14$133
SsdSilver Sulfadiazine12$124
Meloxicam30$65

Paid to pharmacies, not to this prescriber.

Other podiatrist in Warren

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →